12-51794533-A-G
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BS2BS1
This summary comes from the ClinGen Evidence Repository: The c.4687A>G variant in SCN8A is a missense variant predicted to cause the substitution of isoleucine by valine at amino acid 1563 (p.Ile1563Val). The variant is present at a frequency of 0.000008674 (14 alleles) of the total population in gnomAD v4.0, which exceeds the threshold for BS1. Additionally, the variant was identified in 7 unaffected adults who were referred for clinical testing as part as trio exome analysis (internal data, GeneDx, July 2023). It was identified as homozygous in an individual undergoing trio exome sequencing for an unrelated condition, without a neurodevelopmental disorder, in which both parents were heterozygous and unaffected (BS2, GeneDx internal data, July 2023). In summary, this variant meets the criteria for BENIGN for Autosomal Dominant Complex Neurodevelopmental Disorder based on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP (Version 1.0, approved 7/25/23): BS1, BS2 LINK:https://erepo.genome.network/evrepo/ui/classification/CA6571849/MONDO:0100038/070
Frequency
Consequence
NM_001330260.2 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
 - developmental and epileptic encephalopathy, 13Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
 - cognitive impairment with or without cerebellar ataxiaInheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
 - seizures, benign familial infantile, 5Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - benign familial infantile epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - infantile convulsions and choreoathetosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - myoclonus, familial, 2Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SCN8A | NM_001330260.2  | c.4687A>G | p.Ile1563Val | missense_variant | Exon 26 of 27 | ENST00000627620.5 | NP_001317189.1 | |
| SCN8A | NM_014191.4  | c.4687A>G | p.Ile1563Val | missense_variant | Exon 26 of 27 | ENST00000354534.11 | NP_055006.1 | |
| SCN8A | NM_001177984.3  | c.4564A>G | p.Ile1522Val | missense_variant | Exon 25 of 26 | NP_001171455.1 | ||
| SCN8A | NM_001369788.1  | c.4564A>G | p.Ile1522Val | missense_variant | Exon 25 of 26 | NP_001356717.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SCN8A | ENST00000354534.11  | c.4687A>G | p.Ile1563Val | missense_variant | Exon 26 of 27 | 1 | NM_014191.4 | ENSP00000346534.4 | ||
| SCN8A | ENST00000627620.5  | c.4687A>G | p.Ile1563Val | missense_variant | Exon 26 of 27 | 5 | NM_001330260.2 | ENSP00000487583.2 | ||
| SCN8A | ENST00000599343.5  | c.4720A>G | p.Ile1574Val | missense_variant | Exon 25 of 26 | 5 | ENSP00000476447.3 | |||
| SCN8A | ENST00000355133.7  | c.4564A>G | p.Ile1522Val | missense_variant | Exon 24 of 25 | 1 | ENSP00000347255.4 | 
Frequencies
GnomAD3 genomes   AF:  0.0000131  AC: 2AN: 152224Hom.:  1  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.00000803  AC: 2AN: 249196 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.00000821  AC: 12AN: 1461710Hom.:  0  Cov.: 32 AF XY:  0.00000413  AC XY: 3AN XY: 727138 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000131  AC: 2AN: 152224Hom.:  1  Cov.: 31 AF XY:  0.0000269  AC XY: 2AN XY: 74364 show subpopulations 
ClinVar
Submissions by phenotype
not provided    Uncertain:1Benign:1 
- -
- -
Developmental and epileptic encephalopathy    Uncertain:1 
This sequence change replaces isoleucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1563 of the SCN8A protein (p.Ile1563Val). This variant is present in population databases (rs751979396, gnomAD 0.0009%). This missense change has been observed in individual(s) with clinical features of SCN8A-related conditions (internal data). ClinVar contains an entry for this variant (Variation ID: 568706). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SCN8A protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Complex neurodevelopmental disorder    Benign:1 
The c.4687A>G variant in SCN8A is a missense variant predicted to cause the substitution of isoleucine by valine at amino acid 1563 (p.Ile1563Val). The variant is present at a frequency of 0.000008674 (14 alleles) of the total population in gnomAD v4.0, which exceeds the threshold for BS1. Additionally, the variant was identified in 7 unaffected adults who were referred for clinical testing as part as trio exome analysis (internal data, GeneDx, July 2023). It was identified as homozygous in an individual undergoing trio exome sequencing for an unrelated condition, without a neurodevelopmental disorder, in which both parents were heterozygous and unaffected (BS2, GeneDx internal data, July 2023). In summary, this variant meets the criteria for BENIGN for Autosomal Dominant Complex Neurodevelopmental Disorder based on the ACMG/AMP criteria applied, as specified by the ClinGen Epilepsy Sodium Channel VCEP (Version 1.0, approved 7/25/23): BS1, BS2 -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at